Contrast-enhanced echocardiography revealed moderate perfusion in a pulmonary artery mass, successfully differentiating primary pulmonary artery sarcoma from pulmonary thromboembolism.
Case Report (n=1)
No
Contrast-enhanced echocardiography can provide crucial information on tumor perfusion to differentiate rare pulmonary artery sarcomas from pulmonary thromboembolism.
BACKGROUND: Primary pulmonary artery sarcoma (PAS) is an extremely rare malignant tumor with a poor prognosis. The clinical manifestations of PAS are diverse, including dyspnea, chest pain, cough, and hemoptysis. The poor prognosis is often due to delayed diagnosis caused by similarity in imaging findings with pulmonary thromboembolism (PTE). These cues of diagnosis include the "wall eclipsing sign", lobulated bulging margins, gadolinium enhancement during MRI imaging, and FDG uptake during PET/CT imaging. However, there are still many misdiagnoses. CASE PRESENTATION: This article reports a woman of reproductive age presenting with a pulmonary artery mass. The computed tomographic pulmonary angiography and positron emission tomography/computed tomography did not show obvious signs of pulmonary artery sarcoma, however, contrast-enhanced echocardiography showed moderate perfusion, which helped differentiate between pulmonary artery sarcoma and pulmonary artery thrombosis, leading to timely surgical treatment. CONCLUSIONS: PAS is a rare form of cancer that can occasionally be visually similar to PTE on radiographic images. Early diagnosis of PAS is of vital importance to the prognosis of the patients. There are several visual cues that can help differentiate between the two conditions. Additionally, contrast-enhanced echocardiography provides additional information on tumor perfusion, offering another effective approach for a prompt and accurate diagnosis.
Liu et al. (Thu,) conducted a case report in Primary pulmonary artery sarcoma (n=1). Contrast-enhanced echocardiography and surgical resection was evaluated. Contrast-enhanced echocardiography revealed moderate perfusion in a pulmonary artery mass, successfully differentiating primary pulmonary artery sarcoma from pulmonary thromboembolism.